valrubicin has been researched along with Genital Neoplasms, Female in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, F; Hammond, N; Homesley, H; Israel, M; Markman, M; Miller, A; Muggia, F; Norberts, DA; Schink, J; Soper, J; Sweatman, T; Teng, N | 1 |
1 trial(s) available for valrubicin and Genital Neoplasms, Female
| Article | Year |
|---|---|
Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies.
Topics: Aged; Aged, 80 and over; Blood Cell Count; Dose-Response Relationship, Drug; Doxorubicin; Female; Genital Neoplasms, Female; Humans; Injections, Intraperitoneal; Middle Aged; Treatment Outcome | 1996 |